MPL-C monophosphoryl lipid A : Phase II trial to begin

Ribi ImmunoChem Inc. (RIBI) Product: MPL-C monophosphoryl lipid A derived from bacterial endotoxin Indication: Prophylactic in coronary artery bypass graft surgery patients to prevent or reduce risk o...